Aurora Capital Partners, a prominent private equity firm, has announced its acquisition of Cold Chain Technologies (CCT), a leading global provider of thermal packaging solutions for temperature-sensitive shipments. This strategic move marks the seventh investment from Aurora Equity Partners V and underscores Aurora’s focus on partnering with founder-owned businesses to drive growth and innovation.
The partnership was officially announced with enthusiastic statements from both company leaders. CCT President Bob Bohne expressed excitement about collaborating with Aurora Capital Partners, citing their impressive history of success with founder-led businesses and their extensive industry knowledge. He emphasized the strong cultural alignment between the two firms as a key factor in choosing Aurora. Echoing this sentiment, CEO Larry Gordon will continue to lead CCT, along with the existing executive leadership and management teams, ensuring continuity and stability as the company enters this new phase of growth with Aurora Capital Partners.
Aurora Capital Partners: A Strategic Investor in Middle-Market Leaders
Aurora Capital Partners distinguishes itself as a leading private equity firm through its focused investment strategy. The firm prioritizes control investments in middle-market companies that demonstrate strong market positions, operate within stable industries, and possess attractive business models with clear pathways for growth. Aurora Capital Partners is not just a financial investor; they bring significant value to their portfolio companies through their proprietary Strategy & Operations Program and a network of seasoned operating advisors. This hands-on approach is designed to accelerate growth and enhance operational efficiency within their acquired businesses. The firm’s investor base includes major public and corporate pension funds, endowments, and foundations, highlighting their credibility and established presence in the private equity landscape. For those interested in learning more about their investment philosophy and portfolio, Aurora Capital Partners maintains a comprehensive website at www.auroracap.com.
Cold Chain Technologies: Ensuring Integrity in Life Sciences Logistics
Cold Chain Technologies (CCT) has established itself as a critical player in the life sciences supply chain. Specializing in both reusable and single-use thermal packaging solutions, CCT ensures the safe and secure transportation of temperature-sensitive materials. With over 50 years of experience, CCT has earned a reputation for innovation and reliability, serving as a trusted partner to major global life sciences OEMs and distributors. Their expertise is crucial in maintaining the integrity of pharmaceuticals, biologics, and other temperature-sensitive products throughout the shipping process. More details about CCT’s solutions and commitment to the industry can be found at www.coldchaintech.com.
The acquisition of Cold Chain Technologies by Aurora Capital Partners represents a strategic alignment of resources and expertise, poised to propel CCT into its next chapter of expansion and innovation within the vital life sciences sector. This partnership highlights Aurora Capital Partners‘ continued commitment to investing in and growing market-leading companies.
